120 related articles for article (PubMed ID: 17261617)
1. Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency.
Nevyjel M; Pontillo A; Calligaris L; Tommasini A; D'Osualdo A; Waterham HR; Granzotto M; Crovella S; Barbi E; Ventura A
Pediatrics; 2007 Feb; 119(2):e523-7. PubMed ID: 17261617
[TBL] [Abstract][Full Text] [Related]
2. Perinatal manifestation of mevalonate kinase deficiency and efficacy of anakinra.
Peciuliene S; Burnyte B; Gudaitiene R; Rusoniene S; Drazdiene N; Liubsys A; Utkus A
Pediatr Rheumatol Online J; 2016 Mar; 14(1):19. PubMed ID: 27012807
[TBL] [Abstract][Full Text] [Related]
3. Mevalonate pathway: a review of clinical and therapeutical implications.
Buhaescu I; Izzedine H
Clin Biochem; 2007 Jun; 40(9-10):575-84. PubMed ID: 17467679
[TBL] [Abstract][Full Text] [Related]
4. Mevalonate kinase deficiency, a metabolic autoinflammatory disease.
van der Burgh R; Ter Haar NM; Boes ML; Frenkel J
Clin Immunol; 2013 Jun; 147(3):197-206. PubMed ID: 23110805
[TBL] [Abstract][Full Text] [Related]
5. Severe early-onset colitis revealing mevalonate kinase deficiency.
Levy M; Arion A; Berrebi D; Cuisset L; Jeanne-Pasquier C; Bader-Meunier B; Jung C
Pediatrics; 2013 Sep; 132(3):e779-83. PubMed ID: 23979089
[TBL] [Abstract][Full Text] [Related]
6. Clinical, genetic, and therapeutic diversity in 2 patients with severe mevalonate kinase deficiency.
Ruiz Gomez A; Couce ML; Garcia-Villoria J; Torres A; Baña Souto A; Yagüe J; Vilaseca MA; Ribes A; Aróstegui JI
Pediatrics; 2012 Feb; 129(2):e535-9. PubMed ID: 22271696
[TBL] [Abstract][Full Text] [Related]
7. Hematological abnormalities and cholestatic liver disease in two patients with mevalonate kinase deficiency.
Hinson DD; Rogers ZR; Hoffmann GF; Schachtele M; Fingerhut R; Kohlschutter A; Kelley RI; Gibson KM
Am J Med Genet; 1998 Aug; 78(5):408-12. PubMed ID: 9714005
[TBL] [Abstract][Full Text] [Related]
8. Mevalonate kinase deficiency: a survey of 50 patients.
Bader-Meunier B; Florkin B; Sibilia J; Acquaviva C; Hachulla E; Grateau G; Richer O; Farber CM; Fischbach M; Hentgen V; Jego P; Laroche C; Neven B; Lequerré T; Mathian A; Pellier I; Touitou I; Rabier D; Prieur AM; Cuisset L; Quartier P; ;
Pediatrics; 2011 Jul; 128(1):e152-9. PubMed ID: 21708801
[TBL] [Abstract][Full Text] [Related]
9. A novel missense mutation in MVK associated with MK deficiency and dyserythropoietic anemia.
Samkari A; Borzutzky A; Fermo E; Treaba DO; Dedeoglu F; Altura RA
Pediatrics; 2010 Apr; 125(4):e964-8. PubMed ID: 20194276
[TBL] [Abstract][Full Text] [Related]
10. Mevalonate kinase deficiency and autoinflammatory disorders.
Haas D; Hoffmann GF
N Engl J Med; 2007 Jun; 356(26):2671-3. PubMed ID: 17596600
[No Abstract] [Full Text] [Related]
11. Mevalonic acidemia: first case of Japan.
Okamoto N; Nakayama M; Narahara C; Kim H; Fujioka M; Imada I; Arai T; Toda S
Jpn J Hum Genet; 1997 Sep; 42(3):441-4. PubMed ID: 12503192
[TBL] [Abstract][Full Text] [Related]
12. On-demand anakinra treatment is effective in mevalonate kinase deficiency.
Bodar EJ; Kuijk LM; Drenth JP; van der Meer JW; Simon A; Frenkel J
Ann Rheum Dis; 2011 Dec; 70(12):2155-8. PubMed ID: 21859689
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
[TBL] [Abstract][Full Text] [Related]
14. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency.
Mandey SH; Schneiders MS; Koster J; Waterham HR
Hum Mutat; 2006 Aug; 27(8):796-802. PubMed ID: 16835861
[TBL] [Abstract][Full Text] [Related]
15. Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra.
Lequerré T; Vittecoq O; Pouplin S; Klemmer N; Mejjad O; Daragon A; Prieur AM; Le Loët X
Rheumatology (Oxford); 2007 Dec; 46(12):1860-2. PubMed ID: 17965046
[No Abstract] [Full Text] [Related]
16. Hyper-immunoglobulin D syndrome with novel mutations in an afebrile infant.
Cadmus SD; Green R; Carrasco R; Levy ML; Diaz LZ
Pediatr Dermatol; 2018 Jul; 35(4):482-485. PubMed ID: 29600537
[TBL] [Abstract][Full Text] [Related]
17. Clinical, biochemical and morphological features of hepatocerebral syndrome with mitochondrial DNA depletion due to deoxyguanosine kinase deficiency.
Labarthe F; Dobbelaere D; Devisme L; De Muret A; Jardel C; Taanman JW; Gottrand F; Lombès A
J Hepatol; 2005 Aug; 43(2):333-41. PubMed ID: 15964659
[TBL] [Abstract][Full Text] [Related]
18. Mevalonate kinase deficiency and autoinflammation.
Hager EJ; Gibson KM
N Engl J Med; 2007 Nov; 357(18):1871-2. PubMed ID: 17978300
[No Abstract] [Full Text] [Related]
19. Allogeneic bone marrow transplantation in mevalonic aciduria.
Neven B; Valayannopoulos V; Quartier P; Blanche S; Prieur AM; Debré M; Rolland MO; Rabier D; Cuisset L; Cavazzana-Calvo M; de Lonlay P; Fischer A
N Engl J Med; 2007 Jun; 356(26):2700-3. PubMed ID: 17596604
[TBL] [Abstract][Full Text] [Related]
20. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort.
Aróstegui JI; Arnal C; Merino R; Modesto C; Antonia Carballo M; Moreno P; García-Consuegra J; Naranjo A; Ramos E; de Paz P; Rius J; Plaza S; Yagüe J
Arthritis Rheum; 2007 Nov; 56(11):3805-13. PubMed ID: 17968944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
